This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (707) Chemotherapy and Side Effects Management (115) Breast Cancer (300) Pharmacology and Pharmaceutics (120) Pharmacovigilance (176)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/85648, first published .
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Authors of this article:

Ayako Higuchi1 Author Orcid Image ;   Yumiko Koi2 Author Orcid Image ;   Tomoaki Eto1, 3 Author Orcid Image ;   Yuka Maeda1 Author Orcid Image ;   Wakako Tajiri2 Author Orcid Image ;   Junji Kawasaki2 Author Orcid Image ;   Sayuri Akiyoshi2 Author Orcid Image ;   Hideki Ijichi2 Author Orcid Image ;   Yoshiaki Nakamura2 Author Orcid Image ;   Chinami Koga2 Author Orcid Image ;   Mototsugu Shimokawa4 Author Orcid Image ;   Hiroaki Shimizu1, 5 Author Orcid Image ;   Toshihiro Matsumoto1 Author Orcid Image ;   Eriko Tokunaga2 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.